Literature DB >> 20568113

Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.

A Peggy Graveland1, Pawel J Golusinski, Marijke Buijze, Rinze Douma, Nanet Sons, Dirk J Kuik, Elisabeth Bloemena, C René Leemans, Ruud H Brakenhoff, Boudewijn J M Braakhuis.   

Abstract

A major problem in head and neck cancer surgery is the high rate of local relapse (LR). In at least 25% of the surgically treated head and neck squamous cell carcinoma (HNSCC) patients, a genetically defined preneoplastic lesion, also known as "field," can be detected in the surgical margins. A remaining field may be an important cause for the development of LR. The aims of our study are (i) to investigate whether HNSCC patients with an unresected field are more likely to develop LR, and (ii) to identify molecular risk factors that predict malignant transformation of field. We retrospectively studied 35 HNSCC patients of whom 16 patients developed LR and 19 patients remained disease-free for at least 4 years. Loss of heterozygosity (LOH) at chromosomes 3p, 9p and 17p, p53 immunostaining, Ki-67 immunostaining and histopathological grading of all available paraffin-embedded surgical margins was performed, and related to LR. Significant associations were determined by Kaplan-Meier analysis and Cox-proportional hazard models. We show that presence of field is significantly associated with LR and that LOH at 9p and p53 immunostaining have the most predictive potential (hazard ratios 3.17 and 3.46, and p values 0.027 and 0.017, respectively). The combination of LOH at 9p and/or a large p53 positive field is most predictive (hazard ratio 7.06 and p = 0.01). Presence and grade of dysplasia was not associated with LR. These data may have major impact for future diagnostic workup of surgically treated HNSCC patients.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20568113     DOI: 10.1002/ijc.25523

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples.

Authors:  Ana Carolina de Carvalho; Matias Eliseo Melendez; Cristina da Silva Sabato; Edenir Inez Palmero; Lidia Maria Rebolho Batista Arantes; Cristovam Scapulatempo Neto; André Lopes Carvalho
Journal:  Pathol Oncol Res       Date:  2018-08-11       Impact factor: 3.201

Review 2.  Molecular margins in head and neck cancer: Current techniques and future directions.

Authors:  Katelyn O Stepan; Michael M Li; Stephen Y Kang; Sidharth V Puram
Journal:  Oral Oncol       Date:  2020-07-20       Impact factor: 5.337

Review 3.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

Review 4.  The molecular biology of head and neck cancer.

Authors:  C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

5.  Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.

Authors:  Gefter Thiago Batista Correa; Vanessa Fátima Bernardes; Silvia Ferreira de Sousa; Marina Gonçalves Diniz; José Maria Porcaro Salles; Renan Pedra Souza; Alfredo Maurício Batista De-Paula; Ricardo Santiago Gomez; Carolina Cavalieri Gomes
Journal:  Tumour Biol       Date:  2015-06-18

Review 6.  Shifting focus in optical image-guided cancer therapy.

Authors:  Stijn Keereweer; Pieter B A A Van Driel; Dominic J Robinson; Clemens W G M Lowik
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

Review 7.  Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.

Authors:  Jennifer L Hunt; Leon Barnes; James S Lewis; Magdy E Mahfouz; Pieter J Slootweg; Lester D R Thompson; Antonio Cardesa; Kenneth O Devaney; Douglas R Gnepp; William H Westra; Juan P Rodrigo; Julia A Woolgar; Alessandra Rinaldo; Asterios Triantafyllou; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-07       Impact factor: 2.503

8.  Molecular diagnosis of minimal residual disease in head and neck cancer patients.

Authors:  A Peggy Graveland; Boudewijn J M Braakhuis; Simone E J Eerenstein; Remco de Bree; Elisabeth Bloemena; Michiel de Maaker; Michiel W M van den Brekel; Frederike Dijk; Wilma E Mesker; Hans J Tanke; C Rene Leemans; Ruud H Brakenhoff
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

9.  Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.

Authors:  Jenni K Peltonen; Kirsi H Vähäkangas; Henni M Helppi; Risto Bloigu; Paavo Pääkkö; Taina Turpeenniemi-Hujanen
Journal:  Head Neck Oncol       Date:  2011-04-22

10.  LOH detected by microsatellite markers reveals the clonal origin of recurrent laryngeal squamous cell carcinoma.

Authors:  Zhaoyang Cui; Xinliang Pan; Qirong Wang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.